Thinking outside of the box: sales insight using AI

Improve your sales insight using AI

Will 2019 be the year in which pharma sales and marketing teams use augmented intelligence to successfully exploit infinite data? Buzz Lightyear made his first...
Pill packet uk popped out. The impact of Brexit on the regulatory and marketing landscape

The impact of Brexit on the regulatory and marketing landscape

Brexit-related change will define the European pharmaceutical and healthcare sector in 2019, both in terms of how drug products are regulated and how they...

HFMA’s Chris Calkin on how the money in the NHS system works

How does the money flow through the NHS? Here’s the inside intelligence. The complicated structure of the NHS is often impenetrable, even to those who...
new GP contract

New standards launched to improve public involvement in research

New national standards to improve the quality of public involvement in research.

Old sales techniques are history and sales forces must adapt

Despite all the rhetoric about multichannel marketing, patient centricity and the inexorable rise of digital, the most effective sales channel is still standing ‘two...

How to concentrate sales efforts in the right place

Right place, right time In part two of a series looking at the effective use of data, Dr Graham Leask addresses how to concentrate sales...

Sales force awakens to boost ROI

Sales force awakens Karen Bell, Director of Business Development at Ashfield Commercial and Clinical UK, on maximising return on investment.  Sales force effectiveness (SFE) is about...

The rise of digital marketing: pharma and social media

    Social media is a prerequisite for most businesses, but how has the historically reticent pharma industry been adapting? Graeme Smith Managing Partner, Fortis Pharma Consulting The highly–regulated...

Marketing Focus: the shift from treatment to prevention

Read part one of Setting the scene in the June edition of Pf Magazine here. PART TWO: Setting the scene Dr Graham Leask and Stewart Adkins...

Marketing Focus: helping modern marketeers to thrive

PART ONE: Setting the scene Introducing a new series of ‘Marketing Focus’ articles, helping modern marketeers to thrive in the changing healthcare environment. In the first...

Latest articles

People sitting around a desk with laptops and tablets to show Pharma drug approvals round-up: UK, Europe, US

What’s been authorised? UK, Europe, US drug approvals

Pf summarises the UK, Europe and US drug approvals from 20 - 24 Jan 2020. UK The National Institute for Health and Care Excellence published draft...
hands holding smart phones to show Digital interventions for behaviour change

Digital interventions for behaviour change

New NICE guidance looks at digital interventions for behaviour change and suggests that these interventions such as apps, wearable devices and online programmes and...
image of red and blue heart on purple background to show Acute aortic dissection is a 'ticking time bomb'

Acute aortic dissection is a ‘ticking time bomb’

Safety body calls for earlier recognition of ‘ticking time bomb’ aortic dissection to prevent deaths as its new report reveals that up to half...

Popular articles

People sitting around a desk with laptops and tablets to show Pharma drug approvals round-up: UK, Europe, US

What’s been authorised? UK, Europe, US drug approvals

Pf summarises the UK, Europe and US drug approvals from 20 - 24 Jan 2020. UK The National Institute for Health and Care Excellence published draft...
black and white photo of Craig Bradley to show Key publications to impact the UK access environment in 2020

Key publications to impact the UK access environment in 2020

Craig Bradley, Commercial Lead Rare GI at Takeda, PM Society Chair & PM Society Market Access Interest Group Lead, looks at key publications to...
image of lungs, the left lung is bordered by orange, the right by blue to show AstraZeneca's Tagrisso▼ (osimertinib) rejected by NICE for use in NHS England

AstraZeneca’s Tagrisso▼ (osimertinib) rejected by NICE for use in NHS England

The National Institute for Health and Care Excellence (NICE) has published final guidance that does not recommend AstraZeneca's Tagrisso▼ (osimertinib) for use within NHS...
Image of man and woman sat in waiting room holding their stomachs to show NICE rejects Janssen's Stelara for moderate to severe ulcerative colitis

NICE rejects Janssen’s Stelara for moderate to severe ulcerative colitis

The National Institute for Health and Care Excellence (NICE) has not recommended ustekinumab, Janssen's Stelara, for treating moderately to severely active ulcerative colitis in...
Illustration of people meeting at a table that looks like a pill to show Tiofarma admits illegal role in fludrocortisone anti-competitive agreement

Tiofarma admits illegal role in fludrocortisone anti-competitive agreement

Tiofarma has admitted that it took part in a fludrocortisone anti-competitive agreement that resulted in significant price hikes for the essential medicine. This means that...

Subscribe

Sign up to receive your free UK subscription to Pf Magazine and our digital newsletters, for all the essential headlines, Jobs of the Week, and thought-provoking features.

Claim my free subscription